Aslan Pharmaceuticals Ltd ADR
(ASLN)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 03-2019 | 12-2018 | 09-2018 | 06-2018 | 03-2018 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,344 | -42,171 | -30,211 | -19,658 | -8,719 |
| Depreciation Amortization | 118 | 242 | 175 | 117 | 58 |
| Accounts receivable | -1,001 | N/A | N/A | N/A | N/A |
| Accounts payable and accrued liabilities | -1,610 | 1,417 | -352 | -541 | -1,600 |
| Other Working Capital | -3,461 | 1,197 | -713 | -1,207 | -2,370 |
| Other Operating Activity | 3,066 | -154 | 2,026 | 1,448 | 2,651 |
| Operating Cash Flow | $-7,231 | $-39,470 | $-29,076 | $-19,840 | $-9,980 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -2 | -80 | -66 | -41 | -27 |
| Purchase Of Investment | -2 | -11 | -16 | -31 | N/A |
| Purchase Sale Intangibles | N/A | -23,003 | -22,432 | -22,864 | -11,969 |
| Other Investing Activity | 0 | -23,003 | -22,432 | -22,731 | -11,969 |
| Investing Cash Flow | $-4 | $-23,094 | $-22,514 | $-22,802 | $-11,996 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 4,060 | N/A | N/A | N/A |
| Common Stock Issued | N/A | 42,228 | 40,997 | 42,205 | N/A |
| Other Financing Activity | -58 | -5,389 | -4,950 | -4,902 | 0 |
| Financing Cash Flow | $-58 | $40,900 | $36,047 | $37,304 | $N/A |
| Exchange Rate Effect | 252 | N/A | 1,198 | 955 | -993 |
| Beginning Cash Position | 28,717 | 50,573 | 48,893 | 50,393 | 51,293 |
| End Cash Position | 21,676 | 28,909 | 34,548 | 46,009 | 28,324 |
| Net Cash Flow | $-7,041 | $-21,664 | $-14,345 | $-4,384 | $-22,969 |
| Free Cash Flow | |||||
| Operating Cash Flow | -7,231 | -39,470 | -29,076 | -19,840 | -9,980 |
| Capital Expenditure | -3 | -80 | -66 | -41 | -27 |
| Free Cash Flow | -7,234 | -39,550 | -29,142 | -19,881 | -10,007 |